Head-to-head · WeighScore
Lighter You vs telos rx
By GLP-1 ScorecardUpdated
Score comparison
telos rx has the higher recorded score — 85.4/100 to 74.3/100.
telos rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telos offers compounded oral and injectable formats; discounted plans can carry early-exit adjustments.
Before you choose
Before comparing the headline prices, the Lighter You review and the telos rx review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Lighter You vs Tyde Wellness and Lttl vs telos rx compare each of them with another graded program, and the list of alternatives to Lighter You ranks the programs closest to Lighter You on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Sprout Health review covers one graded close to these two, at 79.8/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Lighter You | telos rx |
|---|---|---|
| WeighScore | 74.3/100 | 85.4/100 |
| Grade | C | B |
| Site position | #68 | #13 |
| Semaglutide | $169 per 4 weeks (store and intake price; thirteen charges a year) | Advertised from $99/month injectable; plan-dependent; selected bill unverified. |
| Tirzepatide | $339 per 4 weeks (store and intake price; the marketing site advertises $169) | Advertised from $139/month injectable; from $116/month microdosed injection; selected bills unverified. |
| Coverage | All 50 states plus Washington, D.C. (claimed; the footer says otherwise) | Advertises all 50 states; pharmacy and formulation availability varies. |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Strengths
- The store and the intake agree with each other, so a reader who starts at the store sees the figure that will be charged
- Names four dispensing pharmacies with addresses and phone numbers
- Runs oral, microdose and injectable GLP-1 lines plus a separate peptide sub-brand, so the menu is unusually wide for the price band
- Unlimited video visits and dietitian check-ins are described as included in every plan
- A full refund is offered if a clinician declines the prescription
What to consider
- Tirzepatide is advertised at $169 a month on the marketing site and sold at $339 per four weeks in the store and the intake
- The marketing site says “/mo” and the store bills per four weeks, which is thirteen charges a year rather than twelve
- GLP-1 tablets are advertised at $249 and sold at $279 per four weeks; microdosing is advertised at $96 and sold at $179
- The peptide sub-brand prices the same products differently again — NAD+ at $199 against $229, sermorelin at $175 against $229
- The Terms claim all 50 states plus Washington, D.C. and the footer on the same site says not available in all 50 states
- No clinician, medical group or NPI is named, and no compounding class appears anywhere on the domain
- A dietitian visit is promised on the homepage with an asterisk that resolves to no footnote, and neither the Terms nor the refund policy promises one
Strengths
- Names its care organization and pharmacy partners
- Oral and injectable compounded options
What to consider
- Early cancellation can reprice supplied months
- Entity, denial-refund and lab terms conflict
- Current oral invoice and renewal price unverified
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.